Jeff Yass’s Opus Genetics IRD Stock Holding History

Jeff Yass’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81,400	Closed	-$370K	–	14799
2026 Q1	$370K	Buy	81,400 +35,200	+76%	+$122K	﹤0.01%	10402
2025 Q4	$92.9K	Buy	+46,200	New	+$93.8K	﹤0.01%	11492
2024 Q1	–	Sell	-14,100	Closed	-$42.4K	–	13574
2023 Q4	$42.4K	Buy	+14,100	New	+$41.7K	﹤0.01%	11777
2023 Q3	–	Sell	-150,600	Closed	-$654K	–	13177
2023 Q2	$654K	Buy	+150,600	New	+$715K	﹤0.01%	7686
2022 Q4	–	Sell	-209,000	Closed	-$420K	–	13901
2022 Q3	$420K	Sell	209,000 -12,500	-6%	-$27K	﹤0.01%	8939
2022 Q2	$425K	Buy	221,500 +208,500	+1,604%	+$474K	﹤0.01%	8673
2022 Q1	$42K	Sell	13,000 -80,500	-86%	-$276K	﹤0.01%	12388
2021 Q4	$349K	Buy	93,500 +36,500	+64%	+$146K	﹤0.01%	10119
2021 Q3	$294K	Buy	+57,000	New	+$263K	﹤0.01%	10649
2019 Q3	–	Sell	-3,525	Closed	-$73K	–	10954
2019 Q2	$73K	Buy	3,525 +3,231	+1,099%	+$73K	﹤0.01%	9734
2019 Q1	$7K	Sell	294 -66	-18%	-$2.19K	﹤0.01%	8669
2018 Q4	$16K	Sell	360 -146	-29%	-$8.53K	﹤0.01%	8708
2018 Q3	$43K	Sell	506 -77	-13%	-$5.95K	﹤0.01%	8885
2018 Q2	$39K	Buy	+583	New	+$51.2K	﹤0.01%	9327

Other funds holding IRD

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jeff Yass's IRD Position: Q2 2026 in Review

Jeff Yass reduced its Opus Genetics (IRD) stake by 76% in Q2 2026, selling an estimated $2.92M and leaving 196,897 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #8756.

Jeff Yass first reported a position in IRD in Q4 2014 and has held it in 24 quarters since. The position peaked at $3.75M in Q1 2026. 102 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

Jeff Yass held 196,897 shares of Opus Genetics worth $809K as of Q2 2026.
Jeff Yass sold 626,486 Opus Genetics shares in Q2 2026, an estimated $2.92M.
Opus Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8756 holding.
Jeff Yass first reported a position in Opus Genetics in Q4 2014 and has held it in 24 quarters since.
Jeff Yass's Opus Genetics position peaked at $3.75M in Q1 2026.
102 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.